NeuroSave
San Francisco, US · Founded 2010 · Delaware corporation
Founders & leadership
TK
Thomas KreckExecutive
AS
Andrew ScottExecutive
SR
Seth RodgersNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 3 rounds · 2014–2017
▶$150KraisedAug 2017 · 2 investors · Other Health CareRule 506(b)
▶$150KraisedAug 2017 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas KreckExecutive Officer, Director
- Seth RodgersExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $150K
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$50KraisedOct 2016 · 1 investors · Other Health CareRule 506(b)
▶$50KraisedOct 2016 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas KreckExecutive Officer, Director
- Seth RodgersExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $50K
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedJun 2015 · 17 investors · Other Health CareRule 506(b)
▶$1.1MraisedJun 2015 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas KreckExecutive Officer, Director
- Andrew ScottExecutive Officer
- Seth RodgersExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $1.1M
- First sale
- May 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has NeuroSave raised?
- NeuroSave has disclosed $1.3M raised across 3 rounds.
- Where is NeuroSave headquartered?
- NeuroSave is headquartered in San Francisco, US.